Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Core Laboratories (CLB) Tax Provisions (2022 - 2026)

Core Laboratories filings provide 5 years of Tax Provisions readings, the most recent being -$300000.0 for Q1 2026.

  • On a quarterly basis, Tax Provisions fell 117.18% to -$300000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $13.5 million, a 4.22% decrease, with the full-year FY2025 number at $15.5 million, up 10.48% from a year prior.
  • Tax Provisions hit -$300000.0 in Q1 2026 for Core Laboratories, down from $8.1 million in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $8.5 million in Q4 2023 to a low of -$7.3 million in Q2 2023.
  • Median Tax Provisions over the past 5 years was $3.0 million (2023), compared with a mean of $2.8 million.
  • Biggest five-year swings in Tax Provisions: crashed 508.05% in 2023 and later skyrocketed 171.8% in 2024.
  • Core Laboratories' Tax Provisions stood at $6.6 million in 2022, then soared by 30.15% to $8.5 million in 2023, then plummeted by 52.7% to $4.0 million in 2024, then soared by 100.64% to $8.1 million in 2025, then crashed by 103.71% to -$300000.0 in 2026.
  • The last three reported values for Tax Provisions were -$300000.0 (Q1 2026), $8.1 million (Q4 2025), and $3.8 million (Q3 2025) per Business Quant data.